Aug 8, 2018 | Featured Insights
Last week, Dallas-based Baron & Budd secured a major settlement with Endo Pharmaceuticals Inc. (“Endo”), which agreed to pay $13.25 million for fraudulently marketing Lidoderm for unapproved use. This, the suit claimed, was an alleged violation of federal and... 
Sep 7, 2017 | Featured Insights
Phillips & Cohen and the federal government settled a whistleblower case with two New Mexico health care providers for $12.2 million. The settlement was announced Sept. 1, and alleged that Christus Health and its Santa Fe hospital manipulated federal funding for...